144 related articles for article (PubMed ID: 16690054)
1. Pactimibe stabilizes atherosclerotic plaque through macrophage acyl-CoA:cholesterol acyltransferase inhibition in WHHL rabbits.
Kitayama K; Koga T; Maeda N; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Jun; 539(1-2):81-8. PubMed ID: 16690054
[TBL] [Abstract][Full Text] [Related]
2. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
3. Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis.
Worthley SG; Helft G; Corti R; Worthley MI; Chew DP; Fayad ZA; Zaman AG; Fallon JT; Fuster V; Badimon JJ
Pathophysiol Haemost Thromb; 2007; 36(1):9-17. PubMed ID: 18332609
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
[TBL] [Abstract][Full Text] [Related]
5. Different role of macrophages and vascular smooth muscle cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic (WHHL) rabbit between aorta and coronary artery.
Ohtani H; Shingu T; Chayama K; Hayashi K
Hiroshima J Med Sci; 2008 Jun; 57(2):53-60. PubMed ID: 18717187
[TBL] [Abstract][Full Text] [Related]
6. ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice.
Terasaka N; Miyazaki A; Kasanuki N; Ito K; Ubukata N; Koieyama T; Kitayama K; Tanimoto T; Maeda N; Inaba T
Atherosclerosis; 2007 Feb; 190(2):239-47. PubMed ID: 16626720
[TBL] [Abstract][Full Text] [Related]
7. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
Kitayama K; Koga T; Inaba T; Fujioka T
Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
[TBL] [Abstract][Full Text] [Related]
8. Anti-atherosclerotic effect of E5324, an inhibitor of acyl-CoA:cholesterol acyltransferase, in Watanabe heritable hyperlipidemic rabbits.
Kogushi M; Tanaka H; Ohtsuka I; Yamada T; Kobayashi H; Saeki T; Takada M; Hiyoshi H; Yanagimachi M; Kimura T; Yoshitake S; Saito I
Atherosclerosis; 1996 Aug; 124(2):203-10. PubMed ID: 8830933
[TBL] [Abstract][Full Text] [Related]
9. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation.
Rong JX; Kusunoki J; Oelkers P; Sturley SL; Fisher EA
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):122-7. PubMed ID: 15499046
[TBL] [Abstract][Full Text] [Related]
10. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis.
Watanabe T; Nishio K; Kanome T; Matsuyama TA; Koba S; Sakai T; Sato K; Hongo S; Nose K; Ota H; Kobayashi Y; Katagiri T; Shichiri M; Miyazaki A
Circulation; 2008 Feb; 117(5):638-48. PubMed ID: 18212280
[TBL] [Abstract][Full Text] [Related]
11. A selective ACAT-1 inhibitor, K-604, stimulates collagen production in cultured smooth muscle cells and alters plaque phenotype in apolipoprotein E-knockout mice.
Yoshinaka Y; Shibata H; Kobayashi H; Kuriyama H; Shibuya K; Tanabe S; Watanabe T; Miyazaki A
Atherosclerosis; 2010 Nov; 213(1):85-91. PubMed ID: 20843517
[TBL] [Abstract][Full Text] [Related]
12. Effect of macrophage colony stimulating factor on the advanced atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Watanabe Y; Inaba T; Shimano H; Gotoda T; Kawamura M; Shiomi M; Yazaki Y; Yamada N
Horm Metab Res; 1997 Oct; 29(10):507-9. PubMed ID: 9405978
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Tongxinluo and Simvastatin on the stabilization of vulnerable atherosclerotic plaques of aorta in aortic atherosclerosis and molecular mechanism thereof: a comparative study with rabbits].
Li Z; Yang YJ; Qin XW; Ruan YM; Chen X; Meng L; Zhang HD
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(44):3146-50. PubMed ID: 17313769
[TBL] [Abstract][Full Text] [Related]
14. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occurring aortic and coronary lesions.
Esper E; Runge WJ; Gunther R; Buchwald H
J Lab Clin Med; 1993 Jan; 121(1):103-10. PubMed ID: 8426070
[TBL] [Abstract][Full Text] [Related]
15. Difference between normal and WHHL rabbits in susceptibility to the adrenal toxicity of an acyl-CoA:cholesterol acyltransferase inhibitor, FR145237.
Matsuo M; Hashimoto M; Suzuki J; Iwanami K; Tomoi M; Shimomura K
Toxicol Appl Pharmacol; 1996 Oct; 140(2):387-92. PubMed ID: 8887456
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis in Watanabe heritable hyperlipidaemic rabbits. Evaluation by macroscopic, microscopic and biochemical methods and comparison of atherosclerosis variables.
Hansen BF; Mortensen A; Hansen JF; Ibsen P; Frandsen H; Nordestgaard BG
APMIS; 1994 Mar; 102(3):177-90. PubMed ID: 8185885
[TBL] [Abstract][Full Text] [Related]
17. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall.
Matsuo M; Ito F; Konto A; Aketa M; Tomoi M; Shimomura K
Biochim Biophys Acta; 1995 Dec; 1259(3):254-60. PubMed ID: 8541332
[TBL] [Abstract][Full Text] [Related]
18. Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits.
Shiomi M; Ito T; Tsukada T; Yata T; Watanabe Y; Tsujita Y; Fukami M; Fukushige J; Hosokawa T; Tamura A
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1938-44. PubMed ID: 7583574
[TBL] [Abstract][Full Text] [Related]
19. ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
Meuwese MC; de Groot E; Duivenvoorden R; Trip MD; Ose L; Maritz FJ; Basart DC; Kastelein JJ; Habib R; Davidson MH; Zwinderman AH; Schwocho LR; Stein EA;
JAMA; 2009 Mar; 301(11):1131-9. PubMed ID: 19293413
[TBL] [Abstract][Full Text] [Related]
20. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
Shiomi M; Ito T
Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
